Cite
MLA Citation
L.R. Silverman et al.. “88 BONE MARROW BLAST (BMBL) RESPONSE CORRELATES WITH OVERALL SURVIVAL IN RIGOSERTIB-TREATED PATIENTS WITH HIGHER-RISK MDS AFTER FAILURE OF HYPOMETHYLATING AGENTS (HMAS): A NEW RESPONSE CRITERION?.” Leukemia research, vol. 39, n.d., pp. S44–S45. http://access.bl.uk/ark:/81055/vdc_100059908817.0x000001